Article Versions Notes

Brochet B, Clavelou P, Defer G, De Seze J, Louapre C, Magnin E, Ruet A, Thomas-Anterion C, Vermersch P. Cognitive Impairment in Secondary Progressive Multiple Sclerosis: Effect of Disease Duration, Age, and Progressive Phenotype. Brain Sciences. 2022; 12(2):183. https://doi.org/10.3390/brainsci12020183

Brochet, Bruno, Pierre Clavelou, Gilles Defer, Jérôme De Seze, Céline Louapre, Eloi Magnin, Aurélie Ruet, Catherine Thomas-Anterion, and Patrick Vermersch. 2022. "Cognitive Impairment in Secondary Progressive Multiple Sclerosis: Effect of Disease Duration, Age, and Progressive Phenotype" Brain Sciences 12, no. 2: 183. https://doi.org/10.3390/brainsci12020183

Brochet, B., Clavelou, P., Defer, G., De Seze, J., Louapre, C., Magnin, E., Ruet, A., Thomas-Anterion, C., & Vermersch, P. (2022). Cognitive Impairment in Secondary Progressive Multiple Sclerosis: Effect of Disease Duration, Age, and Progressive Phenotype. Brain Sciences, 12(2), 183. https://doi.org/10.3390/brainsci12020183